Ibrutinib Impurity 45 | CAS 1839099-36-3 - Request Quote
Ibrutinib Impurity 45
| SZ CAT No: | SZ-I005064 |
| CAS No | 1839099-36-3 |
| Mol.F. | C25H27N7O2 |
| Mol.Wt. | 457.5 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ibrutinib Impurity 45 is chemically (R)-3-Amino-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one. Ibrutinib Impurity 45 is supplied with detailed characterization data compliant with regulatory guideline. Ibrutinib Impurity 45 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ibrutinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1839099-36-3
Purchase 1839099-36-3
Order 1839099-36-3
Enquire 1839099-36-3
price of 1839099-36-3
1839099-36-3 Supplier
1839099-36-3 Manufacturer
1839099-36-3 Exporter
buy high quality Ibrutinib Impurity 45
Purchase Ibrutinib Impurity 45
Ibrutinib Impurity 45 suppliers
Ibrutinib Impurity 45 manufacturers
Ibrutinib Impurity 45 price
Order Ibrutinib Impurity 45
Enquire Ibrutinib Impurity 45
Ibrutinib Impurity 45 cost
Ibrutinib Impurity 45 Supplier
Ibrutinib Impurity 45 Distributor
Ibrutinib Impurity 45 for Method Validation
Ibrutinib Reference Standard
Ibrutinib Impurity 45 for ANDA Filing
Ibrutinib Impurity 45 for Forced Degradation Studies
Ibrutinib Impurity 45 Identification Standards
Ibrutinib Impurity 45 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.